Study on the promotion of lymphocytes in patients with COVID-19 by broad-spectrum chemokine receptor inhibitor vMIP-II and its Mechanism of signal transmission in vitro

Signal Transduct Target Ther. 2021 Mar 2;6(1):104. doi: 10.1038/s41392-021-00516-4.

Shiyu Li^#^{1

2}, Shuting Liu^#¹, Zhenyou Jiang^#³, Lixia Feng⁴, Yong Gao⁵, Youyu Chen¹, Anding Xu⁶, Wenhua Huang⁷, Nuofu Zhang⁸, Hanxiao Sun⁹

¹ Institute of Genomic Medicine, College of Pharmacy, Jinan University, Guangzhou, China.
² Department of Anatomy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China.
³ Departments of Microbiology and Immunology, Medical College, Jinan University, Guangzhou, China.
⁴ Nanyang People's Hospital, Henan, China.
⁵ Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
⁶ Guangzhou Overseas Chinese Hospital, Guangzhou, China.
⁷ Department of Anatomy, School of Basic Medical Sciences, Southern Medical University, Guangzhou, China. huangwenhua2009@sina.com.
⁸ Institute of Respiratory Diseases, Guangzhou, China. nfzhanggird@163.com.
⁹ Institute of Genomic Medicine, College of Pharmacy, Jinan University, Guangzhou, China. sunhx718@163.com.

^# Contributed equally.

No abstract available

Publication types